Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Form S-1 what dows it mean?
http://www.docstoc.com/docs/56745914/VIASPACE-GREEN-ENERGY--S-1-Filing
thanks for your answer, it is very instructive to know that there are more paths to follow with positron technollogy after the market for cardiac PETs gets saturated.
question: is the Loma Linda Proton Therapy hospital using POSC machines?
Thx - whatever I do its my own doing, however it's nice to look at the neighbor's grass sometimes. Sooner or later we'll all depend on grass for our energy needs.
what other grass Co do you cotton to? I hope is the good old grass!
What a comeback today, I almost cheked into the hospital earlier...
one more, Rookie,HAPPY BIRTHDAY, may your optimism translate into $$
thanks for your answers - it is just baffling to me: we invested into this company because of one promising product (liquid fuel batteries) that were supposed to revolutionize the portable device market and within a year we were switched to another almost totally unrelated product, GKG (the only common among the two is that it is renewable energy)
What I want to get an idea of is what is the porcentage of time/resources this company is dedicating every day to each of their products - what is the real focus of the company?
Perhaps after the launch of VGREF this will be easier to understand. Ultimately I want to reach a decision wheter to hold my 1 mil+ position here, or to sell-off for the time being with the knowledge that there won't be any pps increase in the forseable future, or maybe to increase my position in this co.
I'm not very good at what's call DD or basic research since I dedicate most of my time to writing, studing and right now buiding a monstruous personal web site, so I do appreciate your comments and sometimes I also trust them.
HEY what happened here? what a strong finish!! wow.
can anybody give me an update on the cartridge part of the business?
Dear Mr lackofcash,
I find you a fascinating person and I am very happy to be your friend via this VSPC Board. I love your stories about the farm life and your vacations, ideas, and so on. You are trully one great American which I admire and respect.
Having said so I would like to ask you why did VSPC "abandon" their fuel potentially profitable cartridge business - what is the latest you have heard about this.
Can you imagine Sir, if BOTH business would turn a profit, the GKG asnd the cartridge business? then you would have to change your moniker to something like toomuchcash.
I'm also super-positive on VSPC and ready willing and able to wait the wait,
have you ever thought about a buy-out or takeover posibility? after all COV is a 19 Billion Market Cap co, and POSC is a paltry 38 million MC co. and COV just merged with EVVV ?
You have to take into account that the capitalization of this co. is only about $8.5mil - if they got a $1.2 mil it only shows how cheap this company is valued. CCLearly a takeover target.
MCLN secured $1.2 million financing in 2nd qt.
some POSITIVE highlights:
Loved that photo of Gomez Addams
Is this the first time VSPC acknowledge they sale to Samsung? this board is like a ghost town and actually I like ghost towns.
I'm also invested in POSC - the dissapointing finish today in both stocks was astounding, yet I'm still confident in both companies. Hang on. Next week MCLN will announce revenues which are going to be UNUSUAL (that's the reason for the week's delay) and POSC is going to finally announce their partnership - it would be painful to sell now and then see the stock(s) soar, IMHO-IMOT
HIGHLIGHT FROM THE PREVIOUS MESSAGE
in addition to the phenomenal GKG I'd like to emphasize the following:
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION
(this is a FANTASTIC UPBEAT review of VSPC)MUST READ!!
http://biz.yahoo.com/e/100816/vspc.ob10-q.html
this is just the first part:
The following discussion contains certain statements that constitute "forward-looking statements". Such statements appear in a number of places in this Report, including, without limitation, "Management's Discussion and Analysis of Financial Condition or Plan of Operation." These statements are not guarantees of future performance and involve risks, uncertainties and requirements that are difficult to predict or are beyond our control. Our future results may differ materially from those currently anticipated depending on a variety of factors, including those described below under "Risks Related to Our Future Operations" and our filings with the Securities and Exchange Commission. The following should be read in conjunction with the unaudited Consolidated Financial Statements and notes thereto that appear elsewhere in this Report and in conjunction with our 2009 Annual Report on Form 10-K as filed with the SEC.
VIASPACE Overview
VIASPACE Inc. ("we", "us", "VIASPACE", or the "Company") is a renewable and alternative energy company with a global reach. We operate three separate businesses. We grow a fast-growing, high yield, low carbon, nonfood energy crop called Giant King Grass ("GKG") which can be burned in 100% biomass power plants to generate electricity; made into pellets that can be burned together with coal to reduce carbon emissions from existing power plants; generate bio methane through anaerobic digestion, and can be used as a feedstock for low carbon liquid biofuels for transportation. Cellulosic ethanol and other liquid biofuels, collectively called Grassoline, do not use corn or other food sources as feedstock. GKG can also be used as animal feed. GKG and other plants absorb and store carbon dioxide from the atmosphere as they grow. When burned, they release the carbon dioxide back into the atmosphere, but it is the same carbon dioxide that was removed from the atmosphere, so the process is carbon neutral. Small amounts of fossil fuel are used by the farm equipment, transportation of GKG and fertilizer, so the overall process is low carbon, but much lower than burning coal or other fossil fuels directly. GKG has been independently tested by customers and been shown to have excellent energy content and very high bio methane production. We also manufacture framed copyrighted artwork in China and market and sell the artwork in the U.S. We produce disposable fuel cartridges that provide the energy source for portable electronics powered by fuel cells. We do not build the power plant or biofuel plant; rather we grow GKG that is needed as the fuel or feedstock. We do not make fuel cells, but instead we make disposable fuel cartridges for fuel cell and electronics manufacturers such as Samsung. Both the grass and the fuel cartridge businesses could represent potentially large and recurring revenue streams. We grow GKG on 280 acres of leased land in China to serve as a nursery for expansion, a demonstration plot for potential partners and customers, to provide samples for potential customers, and as a grass source for our own products. VIASPACE is based in California with business activities in China, Korea and Japan.
VIASPACE was founded in 1998 as a private company to commercialize proven space and defense technologies from NASA and the Department of Defense. VIASPACE has licensed patents, and software technology from California Institute of Technology ("Caltech"), which manages the Jet Propulsion Laboratory ("JPL") for NASA. VIASPACE became a public company on June 22, 2005. On October 21, 2008, the Company and its then wholly-owned subsidiary VIASPACE Green Energy ("VGE"), acquired an equity interest in Inter-Pacific Arts, Corp. ("IPA BVI"), a British Virgin Islands profitable company that manufactures high quality, copyrighted, framed artwork at its factory in the People's Republic of China ("PRC'), and sells the framed art to large retailers in the US. IPA BVI, through its wholly-owned subsidiary, Guangzhou Inter-Pacific Arts Corp., a Chinese wholly owned foreign enterprise registered in Guangdong province ("IPA China") which also has a worldwide license to cultivate and sell GKG.
The Company's web site is www.VIASPACE.com.
Critical accounting policies and estimates
Financial Reporting Release No. 60, "Cautionary Advice Regarding Disclosure About Critical Accounting Policies" ("FRR60") issued by the SEC, suggests that companies provide additional disclosure and commentary on those accounting policies considered most critical. FRR 60 considers an accounting policy to be critical if it is important to the Company's financial condition and results of operations, and requires significant judgment and estimates on the part of management in its application. For a summary of the Company's significant accounting policies, including the critical accounting policies discussed below, see the accompanying notes to the consolidated financial statements.
The preparation of the Company's financial statements in conformity with accounting principles generally accepted in the United States of America ("US GAAP") requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates, which are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. The result of these evaluations forms the basis for making judgments about the carrying values of assets and liabilities and the reported amount of expenses that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions. The following accounting policies require significant management judgments and estimates:
--------------------------------------------------------------------------------
Table of Contents
VIASPACE and DMFCC have generated revenues on product revenue shipments. In accordance with SEC Staff Accounting Bulletin No. 104, "Revenue Recognition"
("SAB No. 104"), VIASPACE and DMFCC recognize product revenue provided (1)
persuasive evidence of an arrangement exists, (2) delivery to the customer has occurred, (3) the selling price is fixed or determinable and (4) collection is reasonably assured. Delivery is considered to have occurred when title and risk of loss have transferred to the customer. The price is considered fixed or determinable when it is not subject to refund or adjustments. Our standard shipping terms are freight on board shipping point. If the Company ships product whereby a customer has a right of return or review period, the Company does not recognize revenue until the right of return or review period has lapsed. Prior to the period lapsing, this revenue would be recorded as deferred revenue on the Company's balance sheet.
Ionfinity has generated revenues to date on fixed-price contracts for government contracts. These contracts have clear milestones and deliverables with distinct values assigned to each milestone. The government is not obligated to pay Ionfinity the complete value of the contract and can cancel the contract if the Company fails to meet a milestone. The milestones do not require the delivery of multiple elements as noted in Emerging Issues Task Force ("EITF") Issue No. 00-21 "Revenue Arrangements with Multiple Deliverables" ("EITF No. 00-21"). In accordance with SAB No. 104, the Company treats each milestone as an individual revenue agreement and only recognizes revenue for each milestone when all the conditions of SAB No. 104 defined earlier are met.
In accordance with SAB No. 104, IPA BVI and IPA China recognize product revenue provided: (1) persuasive evidence of an arrangement exists, (2) delivery to the customer has occurred, (3) the selling price is fixed or determinable and (4) collection is reasonably assured. Delivery is considered to have occurred when title and risk of loss have transferred to the customer. The price is considered fixed or determinable when it is not subject to refund or adjustments. Our standard shipping terms are free on board shipping point. Some of the Company's products are sold in the PRC and are subject to Chinese value-added tax. This VAT may be offset by VAT paid by the Company on raw materials and other materials included in the cost of producing their finished product. Revenue is recorded net of VAT taxes.
The Company accounts for equity instruments issued to consultants and vendors in exchange for goods and services in accordance with EITF Issue No. 96-18, "Accounting for Equity Instruments that are Issued to Other than Employees for Acquiring, or in Conjunction with Selling Goods or Services", and EITF Issue No. 00-18, "Accounting Recognition for Certain Transactions Involving Equity Instruments Granted to Other than Employees". The measurement date for the fair value of the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the consultant or vendor is reached or (ii) the date at which the consultant or vendor's performance is complete. In the case of equity instruments issued to consultants, the fair value of the equity instrument is recognized over the term of the consulting agreement. In accordance with EITF Issue No. 00-18, an asset acquired in exchange for the issuance of fully vested, non-forfeitable equity instruments should not be presented or classified as an offset to equity on the grantor's balance sheet once the equity instrument is granted for accounting purposes. Accordingly, the Company records the fair value of the fully vested, non-forfeitable common stock issued for future consulting services as prepaid expenses in its consolidated balance sheet.
The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. There is no assurance that actual results will not differ from these estimates.
See footnotes in the accompanying financial statements regarding recent financial accounting developments.
Results of Operations
Three Months Ended June 30, 2010 Compared to June 30, 2009
Revenues
Revenues were $764,000 and $1,470,000 for 2010 and 2009, respectively, a decrease of $706,000 or 48%. IPA BVI and IPA China recorded revenues of $620,000 in 2010 from the sales of framed-artwork primarily to retail U.S. customers, a decrease of $660,000 from the comparable period in 2009. Ionfinity incurred revenues of $136,000 in 2010, a decrease of $52,000 from 2009. Ionfinity recorded revenues in both years from a Phase II U.S. Army contract and a Phase II U.S. Navy contract. DMFCC recorded revenues in 2010 of $8,000 from a fuel cell contract it had with Samsung, but did not record any similar revenues in 2010. VIASPACE recorded revenues of $2,000 from a battery sale commercial contract in 2009 and had no battery sale revenues in 2010.
--------------------------------------------------------------------------------
looks like this quarter was not good, hmmm.
FIRST: a stock with no debt NOW: a brand new manufacturing facility - HOW LONG UNTIL PEOPLE FIND ABOUT THIS GEM!!~??
Positron Corporation (OTCBB:POSC), a molecular imaging and solutions company specializing in Nuclear Cardiology and a leader in Cardiac PET, announced today the opening of a cGMP ready (current good manufacturing practices) facility in Indiana for the manufacturing of both radio...
opening bid/ask at TD is 0.0163 x 0.018, so... maybe
No news yet, EITHER
1) somebody knows something and bought a mill shares in anticipation, or
2) VGREF's going to start trading
anyway its a FANTASTIC SIGN of thigs to come probably this week
JUST JUMPED 25% to 0.0185 - LACKOFCASH keep brewing THAT coffe, Man
http://www.americanrecycler.com/0810/357medical.shtmlMedical waste disposal meets humanitarianism
by Mike Breslin
Regulated medical waste (RMW) is a far-reaching term that encompasses everything from syringes to prescription drugs, new and used medical supplies to human and animal parts, to laboratory and hospital equipment. That just begins to describe an entire universe of constituent components.
Adding to the scope of this category is the exploding size of the American healthcare market due to the aging of baby boomers, new technologies requiring ever more supplies, the mushrooming use of prescription drugs and the increased generation of home medical waste. For instance, the obesity problem has triggered more use of onset Type 2 diabetic supplies, like blood testing and insulin syringes, leading to a surge in RMW disposal.
RMW is a complex, ultra sensitive branch of the solid waste stream. It is subject to special regulatory compliance depending on where it is generated, comes with legal liabilities throughout the flow of the waste stream and requires higher collection and disposal costs.
--------------------------------------------------------------------------------
Reuse for humanitarian relief
Because of the challenges facing RMW and the desire of the healthcare industry to ensure public safety and to be environmentally responsible, keeping as much of these wastes out of landfills as possible and recycling whenever practical have become high priorities. As a result, there have emerged a number of innovative alternatives.
Over the past decade, for example, the recovery and reuse of medical supplies and biomedical equipment has grown from virtually nothing to a well-established national supply chain that is now exporting hundreds of thousands of tons annually for reuse to developing countries around the world. Materials that would have been landfilled are now relieving pain and saving lives.
An example is MedShare, a non-profit humanitarian organization founded in 1998 and headquartered in Atlanta. It pioneered the concept of recycling American medical supplies and equipment for people in needy countries.
MedShare has established bin collection programs in the Atlanta and San Francisco metro area hospitals to recover medical supplies that otherwise would be trashed due to hospital regulations. “Since our founding we estimate that we have saved in excess of 1.7 million cubic feet from going into landfills. On average, we recover about 2,500 pounds of surplus medical supplies each week from hospitals in Atlanta and Northern California, thus diverting them from landfills,” said A.B. Short, CEO and cofounder of MedShare.
Hospitals generate large volumes of medical waste, much of it perfectly good medical supplies and equipment. This is partially a result of our litigious society. Once an item is ordered for a patient’s room, the patient is charged for it, and if unused, it must be disposed of. There are also hundreds of different medical-surgical kits used. Often there are separately packaged leftovers as well as damaged packaging, inventory clearances and equipment disposals due to upgrades.
MedShare collects these items, as long as the ones with expiration dates have a shelf life of 12 to 18 months, and receives product donations from medical supply manufacturers and distributors – mostly cosmetically damaged products, overstocks and discontinued lines. It also receives products and equipment from other humanitarian organizations that have found MedShare an efficient conduit to distribute their donations.
With a small staff and approximately 1,000 volunteers per month, MedShare sorts and repackages nearly 25,000 product codes, repairs and refurbishes biomedical equipment ranging from hospital beds to X-ray machines and packs 40 foot containers for export.
Thus far they have shipped nearly 600 containers to hospitals and clinics in the developing world valued at more than $70 million dollars, and have provided medical supplies to more than 1,000 international medical missions worth over $2.3 million.
This recycling model has led to the formation of similar non-profit efforts across the country. In 2008, the MedSurplus Network was established. “The MedSurplus Network is a growing alliance of five medical surplus recovery organizations working together to improve the quality of medical supply and equipment donations here and abroad,” Short explained.
Hospitals are enthusiastic about recovery and reuse organizations. Many are actually paying for the collection service. It’s consistent with their humanitarian efforts and green agendas, plus has the bottom-line benefit of reducing RMW volume thereby reducing disposal costs.
Recovery
The bulk of medical waste is biohazardous. It includes potentially infectious materials such as blood and other biologics, dressings, pharmaceuticals, laboratory waste, and contaminated glassware and sharps – things like needles, syringes and surgical instruments. Virtually any material generated from the medical industry by labs, hospitals, clinics, physicians, dentists, pharmacies and veterinarians can fall into the category of biohazardous.
Laws, regulations, standards and guidelines governing biohazardous materials abound. Many aspects are regulated at the state and local level. Many regulations are based on the United States Environmental Protection Agency’s (EPA) Model Guidelines for State Medical Waste Management. Others are governed by federal regulations issued by the EPA, the Occupational Safety and Health Administration (OSHA), the Department of Transportation (DOT) and United States Postal Service (USPS). The federal government also regulates hazardous elements used in medicine such as mercury and radioactive elements. The EPA’s Medical Waste Tracking Act has established guidelines for the segregation, handling, containment, labeling and transport of medical waste. Most states have developed their medical waste regulatory framework around these guidelines.
Disposal
In the old days, most hospitals used on-site incinerators to dispose of medical wastes, but for the most part those times have passed due to the Clean Air Act, the costs for pollution control systems and the poor environmental image of smoke. Today, hospitals and healthcare practitioners send RMW out to private companies for disposal.
According to the EPA, currently over 90 percent of potentially infectious medical waste is incinerated, but this used to emit highly toxic pollutants like acid gases, carbon monoxide and nitrogen oxides, and are major sources of dioxins and metals such as lead, mercury and cadmium. This caused public opposition to medical waste incineration and many healthcare facilities looked for more environmentally friendly alternatives, primarily industrial sized autoclaves using steam sterilization and often combined with post-processing shredding, microwaving or chemical treatment. Once properly sterilized and shredded, if so required to meet local landfill regulations, RMW can be landfilled as non-hazardous.
Costs for medical waste disposal are much higher than regular solid waste because of the special handling mandated by regulations and the extra treatment required. Like many services, the costs go down as the volume generated goes up. Competition among service providers level out prices of disposal. Medical waste disposal companies are reluctant to talk about costs because it largely depends on volume and nature of the collection customer; frequency and distance for pickup, or if delivered by mail.
But that leaves the perplexing question of how much more does it cost to dispose of biohazardous medical waste than regular solid waste. The only extensive study found on this issue was conducted by Frost and Sullivan, a respected international research and consulting firm. Published in November 2004, ‘U.S. Medical Waste Management and Disposal Markets’ said in part: “…the cost of disposing medical waste is currently over $480 per ton, compared to municipal waste at a cost of around $24 per ton.”
American Recycler spoke to George Winters, manager of marketing and corporate communications for XMED Medical Waste Disposal about typical biomedical collection and disposal practices. Headquartered in Huntsville, Alabama, XMED uses a fleet of trucks to make regular collections of biohazardous waste at hospitals and clinics throughout North Alabama and Southern Tennessee, and has a nationwide mail-back program.
Like most, XMED provides services to anyone who generates sharps or regulated medical waste – from large hospitals to tattoo parlors. Hospitals use small autoclaves to sterilize reusable instruments, but all other contaminated materials must be put in approved biohazard containers.
“We charge by the container, generally 28 or 32 gallon plastic-rubberized containers. Inside the container is a red biohazard bag that must be tied up and the container sealed before pickup,” said Winters.
Smaller containers are used with XMED’s mail-back program – three smaller sized packages for sharps disposal and a five gallon container for regulated medical waste. Biohazardous materials must be mailed in a puncture proof container that is sealed inside a 4 mil plastic liner to meet USPS and DOT regulations.
Materials arriving at XMED’s facility go to industrial autoclaves that handle hundreds of pounds of material and are sterilized using high pressure steam. Sterilized materials are compacted and disposed of according to state and federal regulations.
“We are very environmentally and regulatory compliant in our activities and make sure our process is clean. When we send containers back they are cleaned and sanitized because our customers want it that way,” Winters concluded.
A mobile solution?
American Recycler also spoke with Nicholas Esposito, director of marketing for MedClean Technologies, headquartered in Bethel, Connecticut. Although his company outfits treatment facilities and provides custom built solutions for its customers, MedClean has developed a patent-pending, mobile, self-contained approach for regulated medical waste sterilization and volume reduction.
“To my knowledge, we are the only company offering a mobile or stationary self-contained unit that utilizes autoclave and shredding technology with all utilities on board. It has the ability to be a disaster relief unit because it is self-contained and delivered on demand. With steam and electricity already onboard, the only additional requirement is a simple garden hose, he explained.
The MedClean system uses an onboard steam sterilization unit followed by a separate inline shredder that reduces sharps down to one eighth of an inch size, and red bags to confetti. Once processed, it can go into municipal solid waste dumpsters as non-hazardous.
“The costs associated with operating a MedClean system is under a penny per pound. The total cost to a hospital will depend on the volume of medical waste being addressed. Further, the MedClean System can be acquired as a lease, purchase or rental with no capital outlay. The biggest cost-reduction comes with the ability to address multiple waste streams onsite; red bags, sharps, and confidential documents, with a MedClean System,” said Esposito.
Chemical conversion
It has not escaped the attention of scientists, engineers and entrepreneurs that medical waste is a potentially rich source of chemicals that can be converted into fuels and a wide range of other chemicals. It’s a sound concept: medical waste is totally destroyed, and the energy content is recovered and converted into a synthetic gas which can be reformulated into any number of chemical derivatives such as ethanol. A number of companies are following this path with various technologies, but the volume being processed today is very minimal.
Last year a major development occurred – a joint venture called S4 Energy Solutions was formed between Waste Management, Inc. and InEnTec LLC to develop and operate a series of plasma gasification plants. Initially, the facilities will process medical and industrial waste streams.
Education must begin at home
While collection practices and disposal methods differ, the healthcare industry appears to do a good job of disposing of medical waste driven by regulations, liability issues and professional responsibility. The industry is trending away from incineration to autoclaves.
In most states, however, home generated medical waste is not regulated. This does not apply to regulated medical waste produced by home healthcare workers such as visiting physicians, nurses, therapists or aides. They are supposed to provide for proper disposal.
Home medical waste created through the personal administration of injectable medications, other invasive or noninvasive procedures and surplus or expired prescription drugs are handled differently depending on jurisdiction.
Many counties and municipalities recommend that sharps and other materials be put into a heavy plastic container, closed with a top, sealed with tape, be clearly marked as hazardous medical wastes and put into household trash. This protects waste handlers and segregates hazardous material for incineration or sterilization. Other communities have designated drop off locations or special pick up days.
The sad truth, though, is that far too much medical waste is improperly comingled with household trash, either through laziness or because communities have failed to provide adequate consumer education and convenient means for disposal.
These materials pose serious safety, health and environmental problems. For example, over four billion prescriptions are written annually in the United States. Up to 40 percent dispensed outside hospitals go unused, generating approximately 200 million pounds of pharmaceutical waste each year. Much of this waste goes into sewer systems contaminating water supplies or in landfills doing the same. People often flush disposable syringes down toilets. Because they float, they are difficult to remove at the wastewater treatment plants and can wind up in rivers, the oceans and wash up on beaches.
In fact, it was medical waste washing up on East Coast beaches that first prompted Congress to enact the Medical Waste Tracking Act in 1988. This landmark legislation eventually led to the comprehensive federal and state regulations in place today.
A giant has awaken!!
VIASPACE CEO Discusses Giant King Grass at Industrial Biotechnology Congress in China
Presentation of Comparative Benefits Over Agricultural Waste Draws Positive Responses
By: PR Newswire
Jul. 28, 2010 08:30 AM
IRVINE, Calif., July 28 /PRNewswire-FirstCall/ -- VIASPACE Inc. (OTC Bulletin Board: VSPC), a clean energy company growing Giant King(TM) Grass as a low-carbon, renewable biomass crop, reported that Chief Executive Dr. Carl Kukkonen made an invited presentation at the Third Annual World Congress of Industrial Biotechnology held in Dalian, China, July 25-27, 2010, where more than 500 business executives, industry leaders, technical experts, government officials and investors attended from around the world.
Industrial Biotechnology is an applied field of biology that includes the use of living materials for engineering, producing or manufacturing useful products such as alternative energy, bio-plastics, bio-chemicals, cosmetics and textiles.
The presentation, entitled "Giant King(TM) Grass: High Yield Feedstock for Biofuels, Biogas, Biochemicals and Fuel for Electricity Production," is available on the lower right of the VIASPACE website homepage at www.VIASPACE.com .
Kukkonen commented, "Much of industrial biotechnology focuses on processes to convert biomass into bioenergy, biofuels, biochemicals and other biomaterials and assumes that the required biomass feedstock, typically in the form of agricultural waste, will be readily available when needed and at a reasonable price.
"However, recent experiences in India and China have shown this assumption to be faulty," Kukkonen said. "While energy is needed continuously, most of the biomass power plants in India run at partial capacity because their agricultural waste fuel supplies are seasonal and not available for parts of the year. In addition many power plants have had to close, because the price of agricultural waste has become too high for profitable operations. The trend in China is the same. Agricultural waste -- which was valueless several years ago -- is now in great demand and priced accordingly higher.
"In both countries, we believe we can grow Giant King Grass as a reliable and consistent source of biomass feedstock at a price lower than currently paid for agricultural waste," Kukkonen stated. "This is our value proposition and solution for their ongoing supply problems."
http://investorshub.advfn.com/boards/post_new.aspx?board_id=4206
Kukkonen said that Giant King Grass is suitable for an increasing number of applications: burning in biomass electric power plants; forming into energy pellets for co-firing with coal in coal-burning electric power plants; and producing bio methane by a process known as anaerobic digestion. Biomethane is used to produce electricity and heat, or it can be upgraded into natural gas for supplying natural gas pipelines. The byproduct of anaerobic digestion of Giant King Grass is organic fertilizer that can be recycled for Giant King Grass cultivation. Giant King Grass can also be used as a feedstock for producing liquid biofuels such as cellulosic ethanol and green gasoline called Grassoline. In addition to alternative energy, other potential opportunities for Giant King Grass biomass were discussed, including the manufacture of important industrial chemicals, bioplastics, paper and textiles.
WOW! Tremendous post - you made my dreams come closer to realization - thx.
what do they mean by this? (read at the very bottom)
"There is a failure to deliver in shares of MCLN."
LadyMonteCarlo: WELCOME TO THE BOARD,
I loved your comments and they were very illuminating: "My company is one of less than a handful in Austin that have PET scanners. This study is certainly the future of nuclear testing in cardiology patients and that future has arrived. It offers much better imaging than standard nuclear testing. Last year, in our office, it was geared more toward the overweight patient where traditional imaging was less effective. Today, the study is being ordered for any patient that requires nuclear testing. It is simply a better study. Lastly, the cost of the study is approximately $3500.
Please do post more info like a comparison of prices. PET scan costs $3,500, how much costs a nuclear tech scan? How many years does a PET scan machine lasts? Do you thing POSC will reach 150 machines sold in 2012?
Thanks for all your comments.
Ask at 0.10! ready for a homerun!!
VIASPACE FINANCIAL REPORT FOR 1Q10
Revenues Rise, Operating Expenses Decline, Net Loss Narrows As Company Sets Foundation for Growth of Renewable Energy Business...
more details to come...
what the hell is this? Important Announcement For Viaspace Inc Shareholders (VSPC)Shareholders of VisaSpace Inc (Viaspace and or VSPC) are invited to contact Tanner White PLLC regarding potential compensation
Important Announcement For Viaspace Inc Shareholders (VSPC)
Shareholders of VisaSpace Inc (Viaspace and or VSPC) are invited to contact Tanner White PLLC regarding potential compensation as a result of an ongoing project by the company's M&A team.
FOR IMMEDIATE RELEASE
PRLog (Press Release) – Jul 12, 2010 – Viaspace Inc VSPC shareholders should contact Tanner-White for possible compensation which can potentially consist of cash payments. There will be no fees charged to shareholders and no one will ask them to pay any costs associated with the proceedings.
Reimbursement funds will be limited and VSPC shareholders are asked to make contact without delay. Tanner White PLLC has a team on hand to provide information and assist those shareholders in obtaining compensation.
Inquire via email with the following at this dedicated email address: SNWP@tannerwhite.com
Your name
Address
Number of shares held
Date of purchase
Home/Office/Mobile Telephone numbers
Best time to reach you
A meeting via conference call with cooperating shareholders will be scheduled shortly to discuss the proceedings.
Tanner-White will also be releasing particulars online at their website www.tannerwhite.com to be an online resource where shareholders can track progress and payments.
Moreover, shareholders of Viaspace Inc VSPC are asked to take notice that time is of the essence and invited to make contact at SNWP@tannerwhite.com
Tanner/White PLLC is a leading company in the litigation support, M&A industry.
The company serves corporate legal groups, accountancies, international finance organizations, tax minimization and offshore investors.
--- end --- Visit Press Room
VIASPACE Green Energy Inc. - Website Coming Soon
about:blank http://www.viaspacegreenenergy.com/
VIASPACE VIASENSOR HS-1000
REAL-TIME FUEL CELL HUMIDITY SENSOR
http://www.pdfpick.com/ebook/viasensor-pdf.html
is there here some new info?
justarookie are you listening?
Great post - what are JV's? (sorry for my ignorance)
ask him why it is so hard for a retailer like TrueValue to order logs from the company - this really pi__es me off!
Thank you dannol48 MORE FOR YOUR RARE INSIGHTS than for the analysis.
NO MODERATOR - have you noticed?
I nominate justarookie for super-moderator of this board?
anyone vote for her?
NEW INTEREST ON THE STOCK
abouViaspace Inc. – Alternative Energy – Deals And Alliances Profile—Aarkstore Enterprise Market Research Aggregation
Saturday, July 3rd, 2010 at 12:49 am
VIASPACE Inc. – Alternative Energy – Deals and Alliances Profile
Summary
VIASPACE Inc. – Alternative Energy – Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.
VIASPACE Inc. (VIASPACE) is engaged in operating through two divisions VIASPACE Energy and VIASPACE Security, Inc. to deliver leading edge technology solutions to the global markets for fuel cell energy supply, fuel cell testing, homeland security, commercial security, and national defense, etc. VIASPACE Energy with its subsidiary Direct Methanol Fuel Cell Corporation develops, manufactures, distributes and obtains safety certification for disposable methanol fuel cartridges to provide the energy source for fuel cell-powered products.
And More inside the report…
Recent Developments
Jan 19, 2010: VIASPACE Green Energy Receives Approval For Listing On OTC Bulletin Board
Nov 17, 2009: VIASPACE Reports Revenues Of $1.23 Million In Q3 2009
Nov 02, 2009: VIASPACE Announces U.S. Patent For Micro Fuel Cell Technology
Scope
– Provides key company information for business intelligence needs
– Gives information on the company’s major recent financial deals including mergers & acquisitions, financing of new and acquired assets, PE/VC deals, equity offerings, debt offerings and partnerships.
– Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
For more information, please visit:
http://www.aarkstore.com/reports/VIASPACE-Inc-Alternative-Energy-Deals-and-Alliances-Profile-39809.html
Or email us at press@aarkstore.com or call +919272852585
Aarkstore Enterprise
Tel : +912227453309
Mobile No: +919272852585
Email : contact@aarkstore.com
Website : http://www.aarkstore.com
Blog: http://blogs.aarkstore.com/
Follow us on twitter: http://twitter.com/aarkstoredotcom
t:blank